美国 · SEC FORM 4
Twist Bioscience Corp
TWST · Nasdaq · CIK 0001581280 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
132 同一窗口内观察到的 Form 4 交易行
119 sales · 13 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-05-10 · Cho Dennis.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 10,567,132
- 上期报告
- 12,505,220
- 日均成交量
- 2,757,381
- 回补天数
- 3.8
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
228 transaction lines in the latest 365-day window; 1,646 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Laponis Adam | 卖出 (S) | Common Stock | 2,462 | USD 156.30 | USD 384,823 | SEC 申报 ↗ |
| 2026-10-05 | Leproust Emily M. | 卖出 (S) | Common Stock | 4,548 | USD 202.15 | USD 919,374 | SEC 申报 ↗ |
| 2026-10-02 | WERNER ROBERT F. | 卖出 (S) | Common Stock | 1,482 | USD 188.88 | USD 279,926 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Laponis Adam | 卖出 (S) | Common Stock | 2,462 | USD 156.30 | USD 384,823 | SEC 申报 ↗ |
| 2026-10-05 | Leproust Emily M. | 卖出 (S) | Common Stock | 4,548 | USD 202.15 | USD 919,374 | SEC 申报 ↗ |
| 2026-10-02 | WERNER ROBERT F. | 卖出 (S) | Common Stock | 1,482 | USD 188.88 | USD 279,926 | SEC 申报 ↗ |
| 2026-10-02 | Leproust Emily M. | 卖出 (S) | Common Stock | 45,736 | USD 188.88 | USD 8,638,799 | SEC 申报 ↗ |
| 2026-10-02 | Laponis Adam | 卖出 (S) | Common Stock | 8,057 | USD 188.88 | USD 1,521,838 | SEC 申报 ↗ |
| 2026-10-02 | Green Paula | 卖出 (S) | Common Stock | 10,088 | USD 188.88 | USD 1,905,462 | SEC 申报 ↗ |
| 2026-10-02 | Finn Patrick John | 卖出 (S) | Common Stock | 25,714 | USD 188.88 | USD 4,856,963 | SEC 申报 ↗ |
| 2026-10-02 | Cho Dennis | 卖出 (S) | Common Stock | 9,514 | USD 188.88 | USD 1,797,042 | SEC 申报 ↗ |
| 2026-10-01 | Leproust Emily M. | 卖出 (S) | Common Stock | 655 | USD 200.00 | USD 131,000 | SEC 申报 ↗ |
| 2026-09-24 | Leproust Emily M. | 卖出 (S) | Common Stock | 5,203 | USD 177.38 | USD 922,899 | SEC 申报 ↗ |
| 2026-09-21 | Leproust Emily M. | 卖出 (S) | Common Stock | 1,687 | USD 165.49 | USD 279,182 | SEC 申报 ↗ |
| 2026-09-21 | Green Paula | 卖出 (S) | Common Stock | 294 | USD 165.49 | USD 48,654 | SEC 申报 ↗ |
| 2026-09-21 | Cho Dennis | 卖出 (S) | Common Stock | 348 | USD 165.49 | USD 57,591 | SEC 申报 ↗ |
| 2026-09-17 | Leproust Emily M. | 卖出 (S) | Common Stock | 356,546 | USD 157.99 | USD 56,331,385 | SEC 申报 ↗ |
| 2026-09-17 | Leproust Emily M. | 期权行权/转换 (M) | Common Stock | 208,708 | USD 20.21 | USD 4,218,324 | SEC 申报 ↗ |
| 2026-09-08 | WERNER ROBERT F. | 卖出 (S) | Common Stock | 238 | USD 122.62 | USD 29,184 | SEC 申报 ↗ |
| 2026-09-08 | Leproust Emily M. | 卖出 (S) | Common Stock | 2,302 | USD 122.62 | USD 282,271 | SEC 申报 ↗ |
| 2026-09-08 | Green Paula | 卖出 (S) | Common Stock | 907 | USD 122.62 | USD 111,216 | SEC 申报 ↗ |
| 2026-09-08 | Cho Dennis | 卖出 (S) | Common Stock | 412 | USD 122.62 | USD 50,519 | SEC 申报 ↗ |
| 2026-08-25 | Leproust Emily M. | 卖出 (S) | Common Stock | 41,570 | USD 151.98 | USD 6,317,802 | SEC 申报 ↗ |
| 2026-08-24 | WERNER ROBERT F. | 卖出 (S) | Common Stock | 854 | USD 140.77 | USD 120,218 | SEC 申报 ↗ |
| 2026-08-21 | WERNER ROBERT F. | 卖出 (S) | Common Stock | 669 | USD 139.07 | USD 93,038 | SEC 申报 ↗ |
| 2026-08-21 | Leproust Emily M. | 卖出 (S) | Common Stock | 6,639 | USD 139.07 | USD 923,286 | SEC 申报 ↗ |
| 2026-08-21 | Laponis Adam | 卖出 (S) | Common Stock | 1,965 | USD 139.07 | USD 273,273 | SEC 申报 ↗ |
| 2026-08-21 | Green Paula | 卖出 (S) | Common Stock | 1,360 | USD 139.07 | USD 189,135 | SEC 申报 ↗ |
| 2026-08-21 | Finn Patrick John | 卖出 (S) | Common Stock | 4,046 | USD 139.07 | USD 562,677 | SEC 申报 ↗ |
| 2026-08-21 | Cho Dennis | 卖出 (S) | Common Stock | 1,598 | USD 139.07 | USD 222,234 | SEC 申报 ↗ |
| 2026-08-19 | Cho Dennis | 卖出 (S) | Common Stock | 14,205 | USD 129.75 | USD 1,843,099 | SEC 申报 ↗ |
| 2026-08-18 | Finn Patrick John | 卖出 (S) | Common Stock | 78,355 | USD 117.64 | USD 9,217,707 | SEC 申报 ↗ |
| 2026-08-18 | Finn Patrick John | 期权行权/转换 (M) | Common Stock | 23,355 | USD 67.85 | USD 1,584,637 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | TWST |
| CIK | 0001581280 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 1,646 transaction lines from 2020-01-08 to 2026-10-09 2 P purchase lines · 932 S sale lines · 712 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.